CRISPR Therapeutics AG

$CRSP

Public valuation for CRISPR Therapeutics AG (CRSP). Fair value, signal, and key metrics — no sign-in required.

Current Price $47.99

100% Overvalued

Fair Value Estimate $0

📉 Distressed

Negative earnings with declining revenue

Target: $86.21

80% higher than current

Key Metrics

Market Cap $4.7B

Forward P/E 23.4x

Operating Margin -8933.3%

Revenue Growth -91.4%

Last updated: August 01, 2026

Join the waitlist for valuation updates on $CRSP and the rest of your watchlist.

Stay on this page to join — no sign-in required.